GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
137.47
+6.81 (5.21%)
At close: Oct 28, 2025, 4:00 PM EDT
138.00
+0.53 (0.39%)
After-hours: Oct 28, 2025, 7:58 PM EDT

GeneDx Holdings Statistics

Total Valuation

GeneDx Holdings has a market cap or net worth of $3.97 billion. The enterprise value is $3.93 billion.

Market Cap3.97B
Enterprise Value 3.93B

Important Dates

The last earnings date was Tuesday, October 28, 2025, before market open.

Earnings Date Oct 28, 2025
Ex-Dividend Date n/a

Share Statistics

GeneDx Holdings has 28.89 million shares outstanding. The number of shares has increased by 7.19% in one year.

Current Share Class 28.89M
Shares Outstanding 28.89M
Shares Change (YoY) +7.19%
Shares Change (QoQ) -3.21%
Owned by Insiders (%) 1.55%
Owned by Institutions (%) 93.18%
Float 20.47M

Valuation Ratios

The trailing PE ratio is 1,906.61 and the forward PE ratio is 58.95. GeneDx Holdings's PEG ratio is 1.73.

PE Ratio 1,906.61
Forward PE 58.95
PS Ratio 9.68
Forward PS 8.81
PB Ratio 13.55
P/TBV Ratio 37.16
P/FCF Ratio 256.79
P/OCF Ratio 119.67
PEG Ratio 1.73
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 113.19, with an EV/FCF ratio of 254.08.

EV / Earnings 1,886.48
EV / Sales 9.77
EV / EBITDA 113.19
EV / EBIT 335.40
EV / FCF 254.08

Financial Position

The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.39.

Current Ratio 2.71
Quick Ratio 2.47
Debt / Equity 0.39
Debt / EBITDA 2.71
Debt / FCF 7.32
Interest Coverage 4.31

Financial Efficiency

Return on equity (ROE) is 0.84% and return on invested capital (ROIC) is 2.02%.

Return on Equity (ROE) 0.84%
Return on Assets (ROA) 1.62%
Return on Invested Capital (ROIC) 2.02%
Return on Capital Employed (ROCE) 2.88%
Revenue Per Employee $402,190
Profits Per Employee $2,083
Employee Count1,000
Asset Turnover 0.89
Inventory Turnover 11.44

Taxes

In the past 12 months, GeneDx Holdings has paid $424,000 in taxes.

Income Tax 424,000
Effective Tax Rate 16.91%

Stock Price Statistics

The stock price has increased by +133.71% in the last 52 weeks. The beta is 2.04, so GeneDx Holdings's price volatility has been higher than the market average.

Beta (5Y) 2.04
52-Week Price Change +133.71%
50-Day Moving Average 123.48
200-Day Moving Average 94.83
Relative Strength Index (RSI) 66.02
Average Volume (20 Days) 550,990

Short Selling Information

The latest short interest is 3.00 million, so 10.39% of the outstanding shares have been sold short.

Short Interest 3.00M
Short Previous Month 2.82M
Short % of Shares Out 10.39%
Short % of Float 14.66%
Short Ratio (days to cover) 6.06

Income Statement

In the last 12 months, GeneDx Holdings had revenue of $402.19 million and earned $2.08 million in profits. Earnings per share was $0.07.

Revenue402.19M
Gross Profit 280.16M
Operating Income 11.72M
Pretax Income 2.51M
Net Income 2.08M
EBITDA 34.72M
EBIT 11.72M
Earnings Per Share (EPS) $0.07
Full Income Statement

Balance Sheet

The company has $155.08 million in cash and $113.16 million in debt, giving a net cash position of $41.92 million or $1.45 per share.

Cash & Cash Equivalents 155.08M
Total Debt 113.16M
Net Cash 41.92M
Net Cash Per Share $1.45
Equity (Book Value) 292.26M
Book Value Per Share 10.15
Working Capital 149.96M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $33.19 million and capital expenditures -$17.72 million, giving a free cash flow of $15.47 million.

Operating Cash Flow 33.19M
Capital Expenditures -17.72M
Free Cash Flow 15.47M
FCF Per Share $0.54
Full Cash Flow Statement

Margins

Gross margin is 69.66%, with operating and profit margins of 2.91% and 0.52%.

Gross Margin 69.66%
Operating Margin 2.91%
Pretax Margin 0.62%
Profit Margin 0.52%
EBITDA Margin 8.63%
EBIT Margin 2.91%
FCF Margin 3.85%

Dividends & Yields

GeneDx Holdings does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.19%
Shareholder Yield -7.19%
Earnings Yield 0.05%
FCF Yield 0.39%

Analyst Forecast

The average price target for GeneDx Holdings is $112.22, which is -18.37% lower than the current price. The consensus rating is "Strong Buy".

Price Target $112.22
Price Target Difference -18.37%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 20.32%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 4, 2023. It was a reverse split with a ratio of 1:33.

Last Split Date May 4, 2023
Split Type Reverse
Split Ratio 1:33

Scores

Altman Z-Score n/a
Piotroski F-Score 8